OKLAHOMA CITY, Dec. 13, 2010 (GLOBE NEWSWIRE) -- The law firm of Federman & Sherwood has initiated an investigation into Dionex Corporation (Nasdaq:DNEX) with respect to possible breaches of fiduciary duty by the company's officers and directors, as well as violations of state law in connection with its proposed sale and merger with Thermo Fisher Scientific (NYSE:TMO).
Thermo Fisher has agreed to acquire Dionex for $118.00 per share, for a total purchase price of $2.1 billion, and the sale is expected to close in the first quarter of 2011. Federman & Sherwood is investigating whether the proposed merger makes all necessary disclosures, whether it offers adequate value to the Company's shareholders, and whether Dionex could have received a higher valuation for its shareholders by seeking other purchasers.
If you own common stock in Dionex Corporation and wish to discuss this action, or have any questions or concerns regarding this notice or preservation of your rights, please contact our firm. Federman & Sherwood has extensive experience representing investors in securities, derivative and merger-related shareholder class actions.